Healionics ships its first product, glaucoma treatment for dogs

Healionics Corporation, a start-up biomaterials company in Redmond, announced the sale and shipment of the first commercial product featuring Healionics’ STAR® biomaterial. A company press release says the product, TR-ClarifEYE™, an innovative veterinary glaucoma implant marketed by TR BioSurgical, LLC (TRBIO), is scheduled for limited market launch in April 2009. “We are very excited to announce the first commercial shipment of STAR, which is a significant milestone for Healionics and represents the Company’s first revenue from product sales,” said Healionics CEO Michel Alvarez. In related news, Alvarez replaces Rob Brown as CEO in a management change.

Related external links (will open a new window):

  • Read more in the Healionics press release
  • Read more in Xconomy

    Related WTC links:

  • Healionics is a WTC client
  • This entry was posted in Company_and_Client_News, Healionics, Life_Sciences, RTD. Bookmark the permalink.

    Leave a Reply

    Fill in your details below or click an icon to log in:

    WordPress.com Logo

    You are commenting using your WordPress.com account. Log Out /  Change )

    Google photo

    You are commenting using your Google account. Log Out /  Change )

    Twitter picture

    You are commenting using your Twitter account. Log Out /  Change )

    Facebook photo

    You are commenting using your Facebook account. Log Out /  Change )

    Connecting to %s